➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Patent: 9,815,894

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,815,894
Title:Use of reslizumab to treat moderate to severe eosinophilic asthma
Abstract: Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising administering a therapeutically effective dose of reslizumab to a patient whose symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient\'s blood eosinophil levels are equal to or greater than 400/.mu.L.
Inventor(s): O\'Brien; Christopher (Lafayette Hill, PA), Zangrilli; James (Philadelphia, PA), Shah; Tushar (Flemington, NJ)
Assignee: Cephalon, Inc. (Frazer, PA)
Application Number:14/838,503
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,815,894
Patent Claims:see list of patent claims

Details for Patent 9,815,894

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Teva Respiratory Llc CINQAIR reslizumab INJECTABLE;INJECTION 761033 001 2016-03-23   Start Trial Cephalon, Inc. (Frazer, PA) 2034-09-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.